Phase 2 Withdrawal Clinical Trials
12 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–12 of 12 trials
Recruiting
Phase 2
Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
Chronic PainDrug Dependence of Morphine TypeSymptom, Withdrawal
University of Calgary40 enrolled1 locationNCT04939623
Recruiting
Phase 2
Evaluating Buspirone to Treat Opioid Withdrawal
AnxietyOpioid-use DisorderOpioid Withdrawal+1 more
University of Maryland, Baltimore100 enrolled1 locationNCT05511909
Recruiting
Phase 2
Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
Opioid UseOpiate Withdrawal Syndrome
University of Pennsylvania150 enrolled2 locationsNCT05995535
Recruiting
Phase 2
Prazosin for Alcohol Use Disorder With Withdrawal Symptoms
alcohol withdrawal
Yale University150 enrolled2 locationsNCT04793685
Recruiting
Phase 1Phase 2
ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain
Chronic PainOpioid Withdrawal
Medical University of South Carolina240 enrolled1 locationNCT06442566
Recruiting
Phase 2Phase 3
Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
alcohol withdrawalKetosisAlcohol Use Disorder
University of Pennsylvania30 enrolled1 locationNCT06559995
Recruiting
Phase 2
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
Opioid-use DisorderOpioid WithdrawalOpioid Craving
University of Maryland, Baltimore60 enrolled1 locationNCT05027919
Recruiting
Phase 1Phase 2
Overcoming Nicotine Dependence to Enable Quitting
Smoking CessationSmoking BehaviorsNicotine Dependence+2 more
Rush University Medical Center780 enrolled1 locationNCT05513872
Recruiting
Phase 2Phase 3
The role of flumazenil infusion in the treatment of alcohol withdrawal
Alcohol withdrawal syndrome
Go Medical Industries Pty Ltd45 enrolled1 locationACTRN12617000039381
Terminated
Phase 2Phase 3
The role of flumazenil infusion in the treatment of benzodiazepine withdrawal
Benzodiazepine withdrawal
Go Medical Industries Pty Ltd30 enrolled1 locationACTRN12616001560482
Not Yet Recruiting
Phase 2
Double blind, randomised, placebo controlled trial of Sativex for the management of cannabis withdrawal
Cannabis withdrawal
University of New South Wales50 enrolled1 locationACTRN12611000398909
Not Yet Recruiting
Phase 2Phase 3
A placebo-controlled, randomized clinical trial of Bioeffective A in the management of acute alcohol withdrawal and alcohol abstinence maintenance
alcohol withdrawal
Professor Jon Currie56 enrolled1 locationACTRN12609000649213